Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06449326 · ClinicalTrials.gov registry record · NA
Multimodal Image Analysis and Guidance of Neuromodulation for Trauma-Related Symptoms
A NA study of Post Traumatic Stress Disorder, sponsored by University of New Mexi.
- Recruiting
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 2
- Study locations
NCT06449326: Recruiting NA study of Post Traumatic Stress Disorder, sponsored by University of New Mexi.
NCT06449326 is a NA study of Post Traumatic Stress Disorder that is actively recruiting participants, run by University of New Mexi. The registered enrollment target is 64 participants, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06449326, a NA study of Post Traumatic Stress Disorder, is actively recruiting participants, sponsored by University of New Mexi.
- RECRUITING
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 2
- Study locations
Study Summary
MAGNETS is a prospective, randomized, parallel-design, sham-controlled clinical trial of accelerated, functional magnetic resonance imaging (fMRI)-guided intermittent theta burst stimulation (iTBS) to the right dorsolateral prefrontal cortex (dlPFC) for chronic symptoms of posttraumatic stress disorder (PTSD) in a comorbid Veteran population.
Primary Outcome
Clinician Administered PTSD Scale-DSM 5 (range 0-80; higher scores = more symptoms)
Conditions Studied
Interventions
- DEVICE Active Intermittent theta burst stimulation
- DEVICE Sham Intermittent theta burst stimulation
Study Locations (2)
New Mexico
- UNM Center for Psychiatric Research - Albuquerque
- New Mexico VA Health Care System - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2024-06-01 |
| Est. Completion | 2027-10-01 |
| Phase | NA |
What NCT06449326 shows while recruiting
NCT06449326 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Active Intermittent theta burst stimulation is the first listed.
NCT06449326 reports a single indexed study location in New Mexico.
Frequently Asked Questions
What is clinical trial NCT06449326 about?
NCT06449326 is a clinical study titled "Multimodal Image Analysis and Guidance of Neuromodulation for Trauma-Related Symptoms". MAGNETS is a prospective, randomized, parallel-design, sham-controlled clinical trial of accelerated, functional magnetic resonance imaging (fMRI)-guided intermittent theta burst stimulation (iTBS) to the right dorsolateral prefrontal cortex (dlPFC) for chronic symptoms of posttraumatic stress disor...
What is the current status of trial NCT06449326?
This trial is currently recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2024-06-01. Estimated completion is 2027-10-01.
What conditions does trial NCT06449326 study?
This clinical trial studies the following conditions: Post Traumatic Stress Disorder.
What interventions are being tested in trial NCT06449326?
The interventions under investigation include: Active Intermittent theta burst stimulation (DEVICE), Sham Intermittent theta burst stimulation (DEVICE).
Who is sponsoring clinical trial NCT06449326?
This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06449326 being conducted?
This trial has 2 study locations across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06449326's enrollment target sits among peer trials
64 158th of 262 higher than 105 of 262 other Post Traumatic Stress Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Targeting the Default Mode Network: A TMS-fMRI Study
RECRUITING · NA
-
The Effects of Very Brief Exposure on PTSD in U.S. Combat Veterans
RECRUITING · NA
-
Fear and Avoidance in PTSD Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI